Duration of Dual Antiplatelet Therapy in the Post-Acute Coronary Syndrome Patient.

Abstract

BACKGROUND After acute coronary syndrome, guidelines recommend dual antiplatelet therapy with aspirin and a P2Y12 inhibitor for a period of 12 months for the prevention of secondary cardiovascular events. However, the risk of recurrent ischemic events can persist beyond 12 months, and there has been much debate regarding the benefits of prolonging dual… (More)
DOI: 10.1097/JCN.0000000000000452

Topics

  • Presentations referencing similar topics